BCDAW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW
Should you be buying BioCardia stock or one of its competitors? The main competitors of BioCardia include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
BioCardia (NASDAQ:BCDAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, community ranking, dividends, risk, institutional ownership, media sentiment and analyst recommendations.
BioCardia and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
In the previous week, BioCardia and BioCardia both had 2 articles in the media. BioCardia's average media sentiment score of 1.88 beat 180 Life Sciences' score of 1.87 indicating that BioCardia is being referred to more favorably in the media.
Summary
BioCardia beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.
Get BioCardia News Delivered to You Automatically
Sign up to receive the latest news and ratings for BCDAW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BCDAW vs. The Competition
BioCardia Competitors List
Related Companies and Tools
